iShares Neuroscience and Healthcare ETF
IBRN
4 hedge funds and large institutions have $2.54M invested in iShares Neuroscience and Healthcare ETF in 2025 Q3 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 0 reducing their positions, and 1 closing their positions.
22% more capital invested
Capital invested by funds: $2.08M → $2.54M (+$462K)
0% more funds holding
Funds holding: 4 → 4 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
0.02% less ownership
Funds ownership: 63.32% → 63.3% (-0.02%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HI
Harbour Investments
Madison,
Wisconsin
|
+$1.36K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$1.86K |
IBRN Hedge Fund Activity: Q3 2025 in Review
4 of the 7,638 institutional investors tracked by Wall St. Rank reported a position in iShares Neuroscience and Healthcare ETF (IBRN) for Q3 2025, worth a combined $2.54M — up 22% from $2.08M a quarter earlier.
Fund positioning in IBRN was balanced in Q3 2025: 1 fund opened new positions, 1 closed out, 0 added to existing stakes and 0 trimmed.
The largest buyer was Harbour Investments, opening a new position worth an estimated $1.36K. The largest seller was UBS Group, exiting entirely with an estimated $1.86K sold.
- 4 institutional investors held iShares Neuroscience and Healthcare ETF (IBRN) as of Q3 2025, unchanged from Q2 2025.
- Funds reported $2.54M of iShares Neuroscience and Healthcare ETF stock for Q3 2025, up 22% quarter-over-quarter.
- 1 fund opened new iShares Neuroscience and Healthcare ETF positions in Q3 2025 and 1 closed out, a net change of 0 holders.
- The largest iShares Neuroscience and Healthcare ETF buyer in Q3 2025 was Harbour Investments, an estimated $1.36K added.
- The largest iShares Neuroscience and Healthcare ETF seller in Q3 2025 was UBS Group, an estimated $1.86K sold.
Based on aggregated 13F filings for Q3 2025.